Showing results 2 to 3 of 3
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Cost-effectiveness analysis of additional abiraterone for hormone-sensitive metastatic prostatic cancer treated with androgen deprivation therapy (ADT) Proceeding/Conference:European Society for Medical Oncology (ESMO) Asia Congress, 2017 | 2017 | ||
2017 |